Structure-based and mechanism-based enzyme inhibitor drug design and drug action - Preface

被引:0
|
作者
Silverman, RB [1 ]
机构
[1] NORTHWESTERN UNIV,DEPT CHEM,EVANSTON,IL 60208
关键词
D O I
10.1016/0968-0896(96)80018-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:R13 / R13
页数:1
相关论文
共 50 条
  • [1] MECHANISM-BASED ENZYME-INHIBITORS AS AN APPROACH TO DRUG DESIGN
    BEY, P
    ENZYMES AS TARGETS FOR DRUG DESIGN, 1989, : 59 - 83
  • [2] Structure-based drug design
    Stroud, RM
    FASEB JOURNAL, 1997, 11 (09): : A839 - A839
  • [3] Structure-based drug design
    Henry, CM
    CHEMICAL & ENGINEERING NEWS, 2001, 79 (23) : 69 - +
  • [4] Structure-based drug design
    Kubinyi, H
    CHIMICA OGGI-CHEMISTRY TODAY, 1998, 16 (10) : 17 - 22
  • [5] STRUCTURE-BASED DRUG DESIGN
    MONTGOMERY, JA
    NIWAS, S
    CHEMTECH, 1993, 23 (11) : 30 - 37
  • [6] Structure-based drug design
    Blundell, TL
    NATURE, 1996, 384 (6604) : 23 - 26
  • [7] Structure-based drug design
    Amzel, LM
    CURRENT OPINION IN BIOTECHNOLOGY, 1998, 9 (04) : 366 - 369
  • [8] Structure-based drug design
    Murcko, MA
    Caron, PR
    Charifson, PS
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 297 - 306
  • [9] STRUCTURE-BASED DRUG DESIGN
    COLMAN, PM
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 1994, 4 (06) : 868 - 874
  • [10] Structure-based Drug Metabolism Predictions for Drug Design
    Sun, Hao
    Scott, Dennis O.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 75 (01) : 3 - 17